Fakultní nemocnice Hradec Králové je zdravotnické zařízení v Hradci Králové. Je největší nemocnicí Královéhradeckého kraje a patří k největším nemocnicím v České republice. Jejím zřizovatelem je Ministerstvo zdravotnictví České republiky.

During the past decade, University Hospital Hradec Kralove conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 25 clinical trials were completed, i.e. on average, 39.7% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 14 clinical trials were completed. i.e. 53.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Hradec Kralove" #1 sponsor was "University Hospital Hradec Kralove" with 28 trials, followed by "Boehringer Ingelheim" with 5 trials sponsored, "Czech Lymphoma Study Group" with 4 trials sponsored, "Incyte Corporation" with 4 trials sponsored and "AOP Orphan Pharmaceuticals AG" with 4 trials sponsored. Other sponsors include 60 different institutions and companies that sponsored additional 63 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Hradec Kralove" #1 collaborator was "University Hospital Hradec Kralove" with 5 trials as a collaborator, "Charles University, Czech Republic" with 2 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Hradec Kralove" are "Multiple Myeloma" (3 trials), "Polycythemia Vera" (3 trials), "Bleeding" (2 trials), "Critical Illness" (2 trials) and "Diffuse Large B-cell Lymphoma" (2 trials). Many other conditions were trialed in "University Hospital Hradec Kralove" in a lesser frequency.

Most popular intervention types in "University Hospital Hradec Kralove" are "Drug" (62 trials), "Procedure" (16 trials), "Device" (10 trials), "Other" (8 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Rituximab" (4 trials), "Bortezomib" (3 trials), "Cisplatin" (3 trials) and "Dexamethasone" (3 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Hradec Kralove" are 103 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 36 active trials in "University Hospital Hradec Kralove". 2 are not yet recruiting, 22 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 55 completed trials in University Hospital Hradec Kralove, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Hradec Kralove, 0 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 26 trials that are defined as “Not Applicable".